Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-2.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -244.48% |
| Q3 2025 | 120.73% |
| Q2 2025 | 290.42% |
| Q1 2025 | 72.88% |
| Q4 2024 | -456.36% |
| Q3 2024 | 113.91% |
| Q2 2024 | -366.42% |
| Q1 2024 | 156.33% |
| Q4 2023 | -81.54% |
| Q3 2023 | 172.80% |
| Q2 2023 | -76.31% |
| Q1 2023 | 687.92% |
| Q4 2022 | 115.13% |
| Q3 2022 | 51.06% |
| Q2 2022 | -23.40% |
| Q1 2022 | 31.83% |
| Q4 2021 | 19.99% |
| Q3 2021 | -7.92% |
| Q2 2021 | 15.96% |
| Q1 2021 | -9.94% |
| Q4 2020 | -67.79% |
| Q3 2020 | 12.86% |
| Q2 2020 | -215.21% |
| Q1 2020 | 40.57% |
| Q4 2019 | 11.13% |
| Q3 2019 | 20.96% |
| Q2 2019 | 23.09% |
| Q1 2019 | -63.00% |
| Q4 2018 | -30.82% |
| Q3 2018 | 5.31% |
| Q2 2018 | -39.79% |
| Q1 2018 | 16.29% |
| Q4 2017 | -28.57% |
| Q3 2017 | -11.97% |
| Q2 2017 | -2.49% |
| Q1 2017 | 15.77% |
| Q4 2016 | 0.62% |
| Q3 2016 | -32.34% |
| Q2 2016 | 19.78% |
| Q1 2016 | 7.77% |